Archive - February 2018
Shire, Microsoft and EURODIS form rare diseases alliance
Low flu vaccine efficacy may be due to previous immune history, study finds
Japan’s Oncolys invests £3m in adenovirus firm Unleash Immuno Oncolytics
EHRs do not lower administrative billing costs, study finds
Trump administration to expand access to short-term insurance without ACA protections
SMC approves NHS funding for UCB’s Vimpat in children
SBRI awards £8.7m to primary care projects
Lilly dumps Hanmi’s rheumatoid arthritis med